Status:

COMPLETED

Supplementation of a Leucine-enriched Protein Blend

Lead Sponsor:

McMaster University

Conditions:

Dietary Modification

Diet Habit

Eligibility:

All Genders

18-29 years

Phase:

EARLY_PHASE1

Brief Summary

It is well known that dietary protein transiently stimulates muscle protein synthesis (MPS) whereby changes in MPS in response to feeding may be regulated by specific downstream target proteins of mam...

Detailed Description

In a cross-over, randomized controlled trial, 10 healthy young participants (5 men and 5 women) will be recruited to undergo exercise resistance training randomized to habitual diet or habitual diet a...

Eligibility Criteria

Inclusion

  • Be between the ages of 18-29 years (inclusive)
  • Be able to maintain a habitual diet, physical activity patterns, and body mass throughout the trial
  • Be in general good health
  • Be able to participate in resistance training and aerobic training
  • Understand the study procedures and sign this form providing informed consent to participate in the study
  • Be able to consume a protein bar in the allotted time frame of 10 minutes

Exclusion

  • Smoker
  • Excessive alcohol consumption (more than 21 units of alcohol / week; 1 unit of alcohol is approximately 25 mL of spirits (40% alcohol), 250 mL of beer (4% alcohol) or 75 mL of wine (13% alcohol))
  • Have health problems such as: renal or gastrointestinal disorders, metabolic disease, heart disease, vascular disease, rheumatoid arthritis, diabetes, poor lung function, uncontrolled blood pressure, dizziness, thyroid problems, or any other health conditions for which you are being treated that might put you at risk for this study
  • Have a known or suspected allergy to local anesthetics such as lidocaine
  • Have a dairy protein allergy
  • Participation in another nutrition or exercise research study
  • Do not understand English or have a condition the PI believes would interfere with a participants' ability to provide informed consent, comply with the study protocol, or which might confound the interpretation of the study results or put someone at undue risk
  • Use of medications known to affect protein metabolism (i.e. corticosteroids, or prescription strength acne medications)
  • Consuming a vegan diet
  • Use of an investigational drug product or nutraceutical within the last 30 days
  • Any concurrent medical, orthopedic, or psychiatric condition that, in the opinion of the Investigators, would compromise the ability to comply with the study requirements

Key Trial Info

Start Date :

June 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2020

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT03796897

Start Date

June 1 2019

End Date

March 1 2020

Last Update

June 20 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Exercise Metabolism Research Laboratory, McMaster Univeristy

Hamilton, Ontario, Canada, L8S 4K1